|4Nov 17, 8:12 PM ET

CODE KENNETH REAY 4

4 · BIOLARGO, INC. · Filed Nov 17, 2025

Insider Transaction Report

Form 4
Period: 2025-11-14
CODE KENNETH REAY
DirectorChief Technology Officer10% Owner
Transactions
  • Award

    Common Stock

    2025-11-14$0.16/sh+313,754$50,20125,751,505 total
Footnotes (3)
  • [F1]The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer.
  • [F2]Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
  • [F3]Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.

Documents

2 files